Systemic lupus erythematosus activity and beta two microglobulin levels Atividade do lúpus eritematoso sistêmico e níveis de beta dois microglobulina
dc.contributor.author | Skare T.L. | |
dc.contributor.author | Ferri K. | |
dc.contributor.author | Santos M.A. | |
dc.date.accessioned | 2024-03-13T01:02:12Z | |
dc.date.available | 2024-03-13T01:02:12Z | |
dc.date.issued | 2014 | |
dc.description.abstract | CONTEXT AND OBJECTIVE: Systemic lupus erythematosus (SLE) is an autoimmune disease with a cyclical clinical course. Evaluation of the clinical activity of this disease is important for choosing the correct treatment. The objective of this study was to analyze the value of beta-2 microglobulin (β2M) serum levels in determining SLE clinical activity. DESIGN AND SETTING: Cross-sectional analytical study conducted at the rheumatology outpatient clinic of a private university hospital. METHODS: 129 SLE patients were studied regarding disease activity using SLEDAI (SLE Disease Activity Index) and cumulative damage using SLICC ACR (SLE International Collaborating Clinics/American College of Rheumatology Damage Index for SLE). At the same time, the β2M serum level, ESR (erythrocyte sedimentation rate), anti-dsDNA (anti-double-stranded DNA) and C3 and C4 complement fractions were determined. RESULTS: β2M levels correlated positively with SLEDAI (P = 0.02) and ESR (P = 0.0009) and negatively with C3 (P = 0.007). Patients who were positive for anti-dsDNA had higher β2M serum levels (P = 0.009). CONCLUSION: β2M levels are elevated in SLE patients with active disease. | |
dc.description.firstpage | 239 | |
dc.description.issuenumber | 4 | |
dc.description.lastpage | 242 | |
dc.description.volume | 132 | |
dc.identifier.doi | 10.1590/1516-3180.2014.1324703 | |
dc.identifier.issn | 1516-3180 | |
dc.identifier.uri | https://dspace.mackenzie.br/handle/10899/36478 | |
dc.relation.ispartof | Sao Paulo Medical Journal | |
dc.rights | Acesso Aberto | |
dc.subject.otherlanguage | Acute-phase reaction | |
dc.subject.otherlanguage | Beta 2-microglobulin | |
dc.subject.otherlanguage | Blood sedimentation | |
dc.subject.otherlanguage | Inflammation | |
dc.subject.otherlanguage | Lupus erythematosus, systemic | |
dc.title | Systemic lupus erythematosus activity and beta two microglobulin levels Atividade do lúpus eritematoso sistêmico e níveis de beta dois microglobulina | |
dc.type | Artigo | |
local.scopus.citations | 10 | |
local.scopus.eid | 2-s2.0-84904735864 | |
local.scopus.subject | Adult | |
local.scopus.subject | beta 2-Microglobulin | |
local.scopus.subject | Biological Markers | |
local.scopus.subject | Blood Sedimentation | |
local.scopus.subject | C-Reactive Protein | |
local.scopus.subject | Complement C3 | |
local.scopus.subject | Complement C4 | |
local.scopus.subject | Cross-Sectional Studies | |
local.scopus.subject | Female | |
local.scopus.subject | Hemoglobins | |
local.scopus.subject | Humans | |
local.scopus.subject | Lupus Erythematosus, Systemic | |
local.scopus.subject | Male | |
local.scopus.subject | Middle Aged | |
local.scopus.updated | 2024-05-01 | |
local.scopus.url | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84904735864&origin=inward |